Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression

Cytokine and Growth Factor Reviews

Volumn 12, Issue 2-3, 2001, Pages 171-180

  Julkunen, Ilkka ^a   Sareneva, Timo ^a   Pirhonen, Jaana ^a   Ronni, Tapani ^b   Melén, Krister ^a   Matikainen, Sampsa ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caspases; Chemokines; Cytokines; Influenza A; Transcription factors

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; CASPASE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; STAT PROTEIN; SYNTHETASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A; LEUKOCYTE; MACROPHAGE; NONHUMAN; PATHOGENESIS; RECEPTOR UPREGULATION; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CASPASES; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MACROPHAGES; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0034955802     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(00)00026-5     Document Type: Review

References (88)

1. Orthomyxoviridae: The viruses and their replication
2. Replication of orthomyxoviruses
3. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells
4. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation
5. Apoptosis: A mechanism of cell killing by influenza A and B viruses
6. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells
7. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A)
8. The influenza virus NS1 protein: A novel inhibitor of pre-mRNA splicing
9. Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus
10. How cells respond to interferons
11. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor
12. The 58 000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins
13. Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor
14. Inhibition of double-stranded RNA- and tumor necrosis factor alpha-mediated apoptosis by tetratricopeptide repeat protein and cochaperone P58(IPK)
15. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
16. Induction of apoptosis by influenza virus
17. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection
18. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
19. Influenza virus neuraminidase activates latent transforming growth factor beta
20. Role of neuraminidase in influenza virus-induced apoptosis
21. Chemokines and leukocyte traffic
22. Chemokines: A new classification system and their role in immunity
23. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection
24. Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus
25. Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages
26. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A
27. Expression of cytokines on human bronchial epithelial cells induced by influenza virus A
28. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus
29. Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment
30. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus
31. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus
32. Regulation of IFN-alpha/beta, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells
33. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells
34. The role of interferon in influenza virus tissue tropism
35. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides
36. Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release
37. Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity
38. Virus infection activates IL-1β and IL-18 production in human macrophages by a caspase-1-dependent pathway
39. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
40. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells
41. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: A comparative study
42. Oxidant stress responses in influenza virus pneumonia: Gene expression and transcription factor activation
43. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response
44. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B
45. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase
46. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappaB
47. JNK2 and IKKbeta are required for activating the innate response to viral infection
48. NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase
49. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells
50. The IL-1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense
51. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes
52. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages
53. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells
54. Interferon regulatory factors: The next generation
55. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300
56. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1
57. Regulation of type I interferon gene expression by interferon regulatory factor-3
58. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7
59. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
60. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo
61. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3
62. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs
63. Molecular cloning of the interleukin-1 beta converting enzyme
64. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production
65. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme
66. Interleukin-18: A novel cytokine that augments both innate and acquired immunity
67. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells
68. Interleukin-18 and interleukin-1 beta: Two cytokine substrates for ICE (caspase-1)
69. Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells
70. Functional role of type I and type II interferons in antiviral
71. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
72. Initial and innate responses to viral infections -pattern setting in immunity or disease
73. Type I IFN modulates innate and specific antiviral immunity
74. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus
75. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
76. Interferon-induced Mx proteins form oligomers and contain a putative leucine zipper
77. A functional GTP-binding motif is necessary for antiviral activity of Mx
78. Mutational analysis of murine Mx1 protein: GTP binding core domain is essential for anti-influenza A activity
79. Mx proteins: Mediators of innate resistance to RNA viruses
80. Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product
81. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle
82. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope
83. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
84. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
85. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes in human T cells
86. Type I interferons keep activated T cells alive
87. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells
88. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells